Levosimendan Comes of Age: 20 Years of Clinical Use

Affiliations

¹ Department of Chemistry and Biochemistry, Laboratory of Experimental and Clinical Pharmacology, Faculty of Sciences, Section 1, Lebanese University, Rafic Hariri Educational Campus, Hadat, Lebanon.
² Critical Care Proprietary Products, CO, Orion Pharma, Espoo, Finland.
³ Department of Pharmacology and Toxicology, School of Medicine, University of Mississippi Medical Center, Jackson, MS.

Editorial

Mazen Kurdi et al. J Cardiovasc Pharmacol. 2020 Jul.

. 2020 Jul;76(1):1-3.

doi: 10.1097/FJC.0000000000000850.

¹ Department of Chemistry and Biochemistry, Laboratory of Experimental and Clinical Pharmacology, Faculty of Sciences, Section 1, Lebanese University, Rafic Hariri Educational Campus, Hadat, Lebanon.
² Critical Care Proprietary Products, CO, Orion Pharma, Espoo, Finland.
³ Department of Pharmacology and Toxicology, School of Medicine, University of Mississippi Medical Center, Jackson, MS.

No abstract available

Comment on

Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use.
Papp Z, Agostoni P, Alvarez J, Bettex D, Bouchez S, Brito D, Černý V, Comin-Colet J, Crespo-Leiro MG, Delgado JF, Édes I, Eremenko AA, Farmakis D, Fedele F, Fonseca C, Fruhwald S, Girardis M, Guarracino F, Harjola VP, Heringlake M, Herpain A, Heunks LMA, Husebye T, Ivancan V, Karason K, Kaul S, Kivikko M, Kubica J, Masip J, Matskeplishvili S, Mebazaa A, Nieminen MS, Oliva F, Papp JG, Parissis J, Parkhomenko A, Põder P, Pölzl G, Reinecke A, Ricksten SE, Riha H, Rudiger A, Sarapohja T, Schwinger RHG, Toller W, Tritapepe L, Tschöpe C, Wikström G, Lewinski DV, Vrtovec B, Pollesello P. Papp Z, et al. J Cardiovasc Pharmacol. 2020 Jul;76(1):4-22. doi: 10.1097/FJC.0000000000000859. J Cardiovasc Pharmacol. 2020. PMID: 32639325 Free PMC article. Review.